BridgeBio Pharma SG&A Expense (Quarterly) Insights

BridgeBio Pharma Inc (BBIO)

30.10 -0.94 (-3.04%) USD | NASDAQ | May 17, 16:00

30.10 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	65.81M
December 31, 2023	47.58M
September 30, 2023	35.78M
June 30, 2023	36.12M
March 31, 2023	31.11M
December 31, 2022	31.86M
September 30, 2022	31.19M
June 30, 2022	36.43M
March 31, 2022	43.71M
December 31, 2021	54.75M
September 30, 2021	46.08M
June 30, 2021	45.97M
March 31, 2021	45.41M

Date	Value
December 31, 2020	37.44M
September 30, 2020	36.02M
June 30, 2020	37.97M
March 31, 2020	34.26M
December 31, 2019	34.97M
September 30, 2019	23.50M
June 30, 2019	16.99M
March 31, 2019	18.90M
December 31, 2018	14.38M
September 30, 2018	10.31M
June 30, 2018	10.89M
March 31, 2018	8.007M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

16.99M

Minimum

Jun 2019

65.81M

Maximum

Mar 2024

38.65M

Average

36.27M

Median

SG&A Expense (Quarterly) Benchmarks